170 related articles for article (PubMed ID: 35345062)
1. Efficacy of Lauromacrogol Injection for Ablation of Benign Predominantly Cystic Thyroid Nodules and Related Factors: A Prospective Study.
Dong YJ; Liu ZH; Zhou JQ; Zhan WW
Korean J Radiol; 2022 Apr; 23(4):479-487. PubMed ID: 35345062
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effectiveness of lauromacrogol injection for ablation and microwave ablation in the treatment of predominantly cystic thyroid nodules: a multicentre study.
Min X; Zhang Z; Chen Y; Zhao S; Ge J; Zhao H; Cai Y; Chen H; Shao J; Jing Y; Chen B
BMC Cancer; 2023 Aug; 23(1):785. PubMed ID: 37612615
[TBL] [Abstract][Full Text] [Related]
3. Efficacy Assessment and Analysis of Related Factors of Ultrasound-Guided Percutaneous Lauromacrogol Injection for Cystic Thyroid Nodules.
Gao K; Dai W; Wang F; He S
J Ultrasound Med; 2023 May; 42(5):1093-1101. PubMed ID: 36401842
[TBL] [Abstract][Full Text] [Related]
4. [A preliminary prospective study on the efficacy and safety of ultrasound-guided percutaneous lauromacrogol sclerotherapy in benign cystic or predominantly cystic thyroid nodules].
Chen XX; Zhou Q; Wang F; Wu WW; Shen FX; Gong XH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):33-37. PubMed ID: 30704167
[No Abstract] [Full Text] [Related]
5. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation for Benign Nonfunctional Thyroid Nodules in Children: A Retrospective Study of 62 Patients with Over Four Years of Follow-Up.
Li L; Qiu X
Thyroid; 2022 May; 32(5):525-535. PubMed ID: 34915754
[No Abstract] [Full Text] [Related]
6. Efficacy Assessment of Ultrasound Guided Lauromacrogol Injection for Ablation of Benign Cystic and Predominantly Cystic Thyroid Nodules.
Dong Y; Zhou J; Liu Z; Luo T; Zhan W
Front Pharmacol; 2019; 10():478. PubMed ID: 31139077
[TBL] [Abstract][Full Text] [Related]
7. Sequential treatment by polidocanol and radiofrequency ablation of large benign partially cystic thyroid nodules with solid components: Efficacy and safety.
Lin Y; Li P; Shi YP; Tang XY; Ding M; He Y; Zhai B
Diagn Interv Imaging; 2020 Jun; 101(6):365-372. PubMed ID: 31889636
[TBL] [Abstract][Full Text] [Related]
8. Twelve-Month Volume Reduction Ratio Predicts Regrowth and Time to Regrowth in Thyroid Nodules Submitted to Laser Ablation: A 5-Year Follow-Up Retrospective Study.
Negro R; Greco G; Deandrea M; Rucco M; Trimboli P
Korean J Radiol; 2020 Jun; 21(6):764-772. PubMed ID: 32410415
[TBL] [Abstract][Full Text] [Related]
9. Volume reduction rate of radiofrequency ablation in ≤ 2 cm Bethesda IV thyroid nodules.
Dong Y; Zhan W; Zhou J; Li N; Liu Z; Xia S; Ni X; Liu J; Zhang J; Xu S; Yang Z; Hua Q
Eur Radiol; 2024 Mar; 34(3):1597-1604. PubMed ID: 37665388
[TBL] [Abstract][Full Text] [Related]
10. Initial ablation radio predicting volume reduction from microwave ablation of benign thyroid nodules.
Wu X; Zhang X; Wang K; Zhao S; Shang M; Duan R; Zhang Z; Chen B
Clin Hemorheol Microcirc; 2023; 84(3):263-273. PubMed ID: 36872772
[TBL] [Abstract][Full Text] [Related]
11. Microwave ablation of benign thyroid nodules: 3-year follow-up outcomes.
Luo F; Huang L; Gong X; Han Z; Liu F; Cheng Z; Dou J; Yu X; Liang P; Yu J
Head Neck; 2021 Nov; 43(11):3437-3447. PubMed ID: 34459524
[TBL] [Abstract][Full Text] [Related]
12. Predictor Analysis in Radiofrequency Ablation of Benign Thyroid Nodules: A Single Center Experience.
Bisceglia A; Rossetto R; Garberoglio S; Franzin A; Cerato A; Maletta F; Papotti MG; Ghigo E; Pagano L; Maccario M; Garberoglio R
Front Endocrinol (Lausanne); 2021; 12():638880. PubMed ID: 34079521
[TBL] [Abstract][Full Text] [Related]
13. Inter-observer reliability in ultrasound measurement of benign thyroid nodules in the follow-up of radiofrequency ablation: a retrospective study.
Yan L; Luo Y; Song Q; Li N; Xiao J; Zhang Y; Zhu Y
Int J Hyperthermia; 2020 Nov; 37(1):1336-1344. PubMed ID: 33251890
[TBL] [Abstract][Full Text] [Related]
14. Computer-Analyzed Ultrasound Predictors of the Treatment Efficacy of Radiofrequency Ablation for Benign Thyroid Nodules.
Kuo CY; Wu MH; Ko WC; Cheng SP
World J Surg; 2022 Jan; 46(1):112-120. PubMed ID: 34608544
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Ultrasound-Guided Percutaneous Polidocanol Injection Versus Percutaneous Ethanol Injection for Treatment of Benign Cystic Thyroid Nodules.
Gong X; Wang F; Du H; Chen X; Shi B
J Ultrasound Med; 2018 Jun; 37(6):1423-1429. PubMed ID: 29219197
[TBL] [Abstract][Full Text] [Related]
16. Monopolar Radiofrequency Ablation of Thyroid Nodules: A Prospective Austrian Single-Center Study.
Dobnig H; Amrein K
Thyroid; 2018 Apr; 28(4):472-480. PubMed ID: 29490593
[TBL] [Abstract][Full Text] [Related]
17. Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules.
Yan L; Luo Y; Xie F; Zhang M; Xiao J
Int J Hyperthermia; 2020; 37(1):1139-1148. PubMed ID: 32996790
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency Ablation of Thyroid Nodules: A Long-Term Prospective Study of 24 Patients.
Aldea Martínez J; Aldea Viana L; López Martínez JL; Ruiz Pérez E
J Vasc Interv Radiol; 2019 Oct; 30(10):1567-1573. PubMed ID: 31375448
[TBL] [Abstract][Full Text] [Related]
19. Microwave ablation for large benign thyroid nodules: a proposal for a new approach: "the fluid-motion technique".
Aliberti C; Impellizzeri H; Inama M; Moretto G; Vitali A; Balduzzi A; Toaiari M; Francia G; Casaril A
Updates Surg; 2024 Jan; 76(1):239-244. PubMed ID: 37899391
[TBL] [Abstract][Full Text] [Related]
20. Solid benign thyroid nodules (>10 ml): a retrospective study on the efficacy and safety of sonographically guided ethanol ablation combined with radiofrequency ablation.
Zhu Y; Zhang M; Jin Z; Tian X; Zhang Y; Xie F; Song Q; Yan L; Jiang B; Tang J; Luo Y
Int J Hyperthermia; 2020; 37(1):157-167. PubMed ID: 32024398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
